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Abstract
There remains a critical need for new therapeutics that promote wound healing in patients suffering from chronic skin
wounds. This is, in part, due to a shortage of simple, physiologically and clinically relevant test systems for investigating
candidate agents. The skin of amphibians possesses a remarkable regenerative capacity, which remains insufficiently
explored for clinical purposes. Combining comparative biology with a translational medicine approach, we report the
development and application of a simple ex vivo frog (Xenopus tropicalis) skin organ culture system that permits exploration
of the effects of amphibian skin-derived agents on re-epithelialisation in both frog and human skin. Using this amphibian
model, we identify thyrotropin-releasing hormone (TRH) as a novel stimulant of epidermal regeneration. Moving to a
complementary human ex vivo wounded skin assay, we demonstrate that the effects of TRH are conserved across the
amphibian-mammalian divide: TRH stimulates wound closure and formation of neo-epidermis in organ-cultured human
skin, accompanied by increased keratinocyte proliferation and wound healing-associated differentiation (cytokeratin 6
expression). Thus, TRH represents a novel, clinically relevant neuroendocrine wound repair promoter that deserves further
exploration. These complementary frog and human skin ex vivo assays encourage a comparative biology approach in future
wound healing research so as to facilitate the rapid identification and preclinical testing of novel, evolutionarily conserved,
and clinically relevant wound healing promoters.
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Introduction
Non-healing skin ulcers represent an area of major clinical
challenge [1–4] urgently requiring more effective and safe
treatments. Specifically, topical agents are required that can
induce and/or promote wound re-epithelialisation, a critical
limiting factor in chronic wounds [1,5–7]. While keratinocyte
mitogens, such as cytokines and growth factors, have been
identified in animal studies [8,9] few have made it into the clinical
trial stage and even fewer into daily clinical practice. In seeking
additional potential wound-healing promoters, we have therefore
moved outside the traditional animal models of cutaneous wound
repair (mouse, rabbit, pig) and have employed the consecutive
organ culture of adult frog and human skin as a cross-species
wound healing research system that facilitates the rapid identifi-
cation and preclinical testing of novel, evolutionarily conserved,
and clinically relevant wound healing promoters.
Amphibians and lizards show highly efficient wound repair [10–
14] up to the point of regeneration of an entire limb or tail in
juvenile animals [15–17]. Frog and human skin share the same
evolutionary ancestry and basic architecture and although frog
skin dermis differs from its mammalian counterpart with respect to
its gland-rich stratum spinosum, its collagen-rich stratum compactum
closely resembles mammalian dermis [16,17] (see also Figure 1).
Assuming that the broad mechanisms of wound healing are
conserved between human and frog skin, we suggest that the
systematic study of regenerative amphibian healing may reveal
important pointers as to how human skin wound healing may be
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promoted. We have been drawn to those conserved neuroendo-
crine molecules that are abundant in frog skin. Specifically we
have investigated in this study the potential role of thyrotropin-
releasing hormone (TRH) in cutaneous wound repair in the frog.
TRH, the chief hypothalamic regulator of thyroid hormone
production [18,19], is abundant in adult frog skin (Xenopus laevis
skin contains up to 15 mg/g of TRH) [20,21]. TRH is also present
in human skin [22] where it acts as a potent stimulator of human
hair growth, follicle keratinocyte proliferation and mitochondrial
Figure 1. Wound healing assay design and morphology of Xenopus tropicalis and human skin. (A) Diagram of the ‘punch within a punch’
biopsy injury inflicted on both X. tropicalis and human skin (not to scale). (B) X. tropicalis punch-in-a-punch biopsy. (C) Human skin punch-in-a-punch
biopsy. Full thickness X. tropicalis (D) and human skin (F) with white lines demarcating epidermis (Ep), dermis (De) and hypodermis/subcutis (Hd).
Black arrows in (D) indicate the margins of the stratum spongiosum (SSp) stratum compactum (SCo). A smaller mucous (Mu) and larger granular/poison
(Gr) gland are indicated (D). Human sebaceous glands (SG) and sweat glands (SW) and hair follicle (HF) are indicated (F). Higher magnification images
(E & G) display the epidermis, specifically indicating Stratum germinativum (SGe), Stratum spinosum (SSp) and Stratum corneum (SCo) of frog
epidermis (C) and Stratum basale (Sba) stratum spinosum (SSp), Stratum granulosum (SGr), Stratum Lucidum (SLu) and Stratum corneum (SCo) of human
epidermis (G). A white arrow shows the location of a melanocyte (Mel) at the dermal-epidermal junction. (E). Scale bars in D and F= 300 mm and in E
and G= 50 mm.
doi:10.1371/journal.pone.0073596.g001
TRH and Wound Healing in Frog and Human
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energy metabolism in situ [22–24]. Since there are multiple
biological parallels between hair growth and wound healing [25–
28], we hypothesised that, a) TRH may also function as a novel
promoter of frog skin wound healing, and b) this role may be
conserved in human skin healing as TRH is identical in frogs and
humans [31].
To investigate this hypothesis, we have developed a reproduc-
ible ex vivo assay for amphibian skin wound healing that, when
paired with a complementary human ex vivo assay, facilitates a
comparative biology approach to vertebrate wound healing
research across the amphibian-human species divide. We believe
that this cross-species, comparative approach provides an impor-
tant technical advance over previously reported ex vivo wound
healing models [29,30]. Drawing upon the long tradition of
amphibian skin organ culture [32–35], we identified the skin of
adult X. tropicalis frogs as being optimally suited to organ culture.
In contrast to X. laevis, skin explants from X tropicalis displayed
minimal shrinkage during culture, were less prone to infection, and
can be incubated at higher temperatures (25uC). A basic organ
culture design [36] previously optimised for human skin organ
culture [37] was chosen to maximise the cross-species comparative
potential of this complimentary assay system. In parallel, we
developed a complimentary ex vivo human skin wound healing
assay based on the same design [36]. In contrast to a recently
published model in which partial thickness human skin and
superficial incisional wounds were studied in serum-supplemented
DMEMmedium [29], our assay employs full-thickness human and
frog skin, injured with excisional punch wounds and a serum-free
medium that is essentially identical between the frog and human
wounded skin assays (corrected only for osmolality).
By culturing both X. tropicalis and human skin explants in the
absence of serum, effective wound healing was impaired (as
previously described) [38], allowing for the effects of putative
wound healing stimulatory agents to be investigated. In both
systems, the addition of serum (frog or human, respectively) or
estrogen, both well-established wound-healing promoters in
rodents and man [38,39], were employed as positive controls.
Use of essentially the same medium for both the frog and human
skin wound healing assay further facilitates the cross-species
comparison of test agents.
Using this comparative biology approach, we demonstrate that
TRH stimulates re-epithelialisation in both adult frog and adult
human skin, thus identifying this endogenous peptide neurohor-
mone of frog and human skin as a novel, clinically relevant and
evolutionarily conserved promoter of cutaneous wound healing
across distant vertebrate species.
Materials and Methods
Ethics Statement
All experiments were performed according to the Helsinki
guidelines and following approval by the Institutional Research
Ethics Committee of the University of Lu¨beck. All patients
provided both written and verbal informed consent. Consent
forms (Version number 06–109) were approved for use by the
Institutional Research Ethics Committee of the University of
Lu¨beck. Tissue harvesting from sacrificed animals was governed
by UK Home Office guidelines. Tissue harvesting from Schedule
1 sacrificed animals was covered by guidelines laid down by the
University of Manchester Animal Welfare Centre following the
UK Home Office Animal Licence Act, 1997.
Frog Skin Wound Healing Assay
Male and female adult X. tropicalis frogs (approximately 2 years
old) were sacrificed. Dorsal skin was decontaminated using a non-
alcoholic disinfectant (OcteniseptH spray; Schuelke, Germany),
and removed by incising through the middle of the lateral line
system with surgical scissors (World Precision Instruments,
Hitchin, UK). Skin was placed into 50 ml of Williams E (WE)
medium in a 120 mm tissue culture dish, containing 200 IU/mL
penicillin/20 mg/mL streptomycin, for two hours at 2% CO2,
25uC. Skin sheets were placed dorsal side up on a flat, sterile
surface, striving for minimal skin trauma so as to reduce frog skin
mucous production. Circular wounds were inflicted: First, 6 mm
punches were cut into skin using a biopsy punch (PFM, Ko¨ln,
Germany). Smaller (2 mm) biopsy punches were then used to
create ‘‘punch-in-a-punch’’ skin wounds (Figure 1). These were
individually placed, with the epidermis facing up, in 24-well plates
and cultured in serum-free WE medium diluted 1:1 in sterile
distilled water, supplemented with 10 mg/mL insulin, 10 ng/mL
hydrocortisone, 2 mM L-glutamine and 100 IU/mL penicillin/
10 mg/mL streptomycin. Frog skin explants were cultured in the
absence (negative control) or presence of 5% frog serum isolated
from X. laevis adult female frogs ( = positive control). In addition,
17b-estradiol was investigated as an additional positive control
substance for the promotion of wound healing [39]. Biopsies were
harvested at day 0, day 1, day 3 and day 7 with media changes
every 48 hours.
Assessment of Re-epithelialisation, and Immuno/
Histomorphometric Analysis of Proliferation and
Apoptosis
The progression of re-epithelialisation within the interior 2 mm
wound circle was assessed microscopically using a Leica DMIL
inverted microscope (Leica GmbH, Wetzlar, Germany) fitted with
a Panasonic DMC-L10 (Panasonic, Osaka, Japan) SLR camera.
The degree of re-epithelialisation within the wound area was
calculated as previously described [40].
For paraffin sections, skin biopsies were fixed in zinc fixative
before paraffin embedding. 7 mm thick paraffin sections were cut
from each specimen, and stained with haematoxylin and eosin
(H&E). For frozen sections, skin fragments were embedded in
Shandon Cryomatrix (Thermo Fisher Scientific; Waltham, MA,
U.S.A.) and snap frozen in liquid N2 before 7 mm thick
cryosections were prepared for analyses.
Figure 2. Frog serum and estrogen promote re-epithelialisation and proliferation in Xenopus tropicalis skin. (A) Representative images
of re-epithelialisation sheet in control, 5% frog serum and 100 nM 17b-estradiol (Est)-treated punch wounds at day 7 in culture (scale bars: 0.5 mm).
White-hatched lines indicate the leading edge of new epithelial sheets. (B) Representative images of PH3-positive cells in control, 5% frog serum and
100 nM 17b-estradiol-treated punch wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. (C) Representative images
of TUNEL-positive cells in control, 5% frog serum and 100 nM 17b-estradiol-treated punch wounds at day 7 in culture. The white-hatched line
demarcates new epithelial tongue. Scale bars in (B) and (C) are 100 mm. (D) The graph shows the percentage reduction in wound-area of Xenopus
tropicalis punch wounds in control, 5% frog serum (FS) and 100 nM 17b-estradiol-treated skin. (E) Percentage of proliferative (PH3-positive) cells
present in the new epithelial tongue during re-epithelialisation. (F) Percentage of apoptotic (TUNEL-positive) cells present in the new epithelial
tongue during re-epithelialisation. Data are mean 6 SEM of 4–5 frogs (2 male and 3 female). Significance relative to control data at the same time-
point denoted by *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0073596.g002
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To assess proliferation, immunohistochemical analysis of the
mitosis marker phospho-histone H3 (PH3) with a specific antibody
(Millipore, CA, U.S.A.; 1:1000) was performed on acetone-fixed
cryosections. Following overnight incubation with the primary
antibody, secondary immunofluorescence was detected using the
Alexa Fluor 488 probe (Molecular Probes, Eugene, OR). Nuclei
were visualized with 4, 6-diamino-2-phenylindole (DAPI; 1 mg/
mL). As an additional assessment of proliferation in frog skin,
Weigerts iron-haematoxylin histochemistry was performed in
order to identify mitotic figures. Briefly, slides were deparaffinised
and placed in freshly mixed Alcoholic Haematoxylin and Acid
Aqueous Ferric Chloride solution for two hours. They were then
differentiated in 0.5% acid alcohol before ‘blueing’ in running tap
water. Finally, slides were counterstained with Eosin, rinsed in
running tap water and mounted.
Apoptotic cells were detected using the TUNEL method
(Apoptag H fluorescein detection kit; Millipore, Watford, UK).
Images were captured using a Keyence Biozero-8000 Microscope
(Keyence Corporation, Osaka, Japan). Analysis of carefully
defined reference areas was performed as previously described
[41–44] using NIH ImageJ software (National Institutes of Health,
Bethesda, MD, U.S.A.).
Estradiol and TRH ELISA
The estradiol concentration in frog serum was determined using
the enzyme immunoassay kit Estradiol EIA (Cayman Chemical,
Ann Arbor, USA) according to manufacturer’s guidelines. The
TRH ELISA kit (Uscn Life Science Inc, Wuhan, China) was used,
according to manufacturer’s guidelines, for determining TRH frog
serum concentrations.
Human Wound Healing Organ Culture Assay
Excess scalp and body skin from 4 women (52, 60, 66 and 67
years of age) undergoing elective cosmetic surgery was obtained
after informed consent and ethics approval (University of Lu¨beck,
Germany). The ‘‘punch-in-a-punch’’ design [36] was employed
(2 mm and 4 mm circular wounds, Figure 1), the notable
difference being that hair-bearing, full-thickness (i.e. including
subcutaneous fat) adult human skin was used, with cultures
performed using serum-free WE medium optimized for human hair
Figure 3. Xenopus tropicalis wound closure: promotion of re-epithelialisation and proliferation by TRH. (A) Representative images of the
re-epithelialisation sheet in control, 10 nM and 10 mM TRH-treated punch wounds at day 7 in culture (scale bars: 0.5 mm). White-hatched lines
indicate the leading edge of new epithelial sheets. (B) Representative images of PH3-positive cells in control, 10 nM and 10 mM TRH-treated punch
wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. (C) Representative images of TUNEL-positive cells in control,
10 nM and 10 mM TRH-treated punch wounds at day 7 in culture. The white-hatched line demarcates new epithelial tongue. Scale bars in (B) and (C)
are 100 mm. (D) The graph shows the percentage reduction in wound-area of X. tropicalis punch wounds in control, 10 nM and 10 mM TRH-treated
skin. (E) Percentage of proliferative (PH3-positive) cells present in the new epithelial tongue during re-epithelialisation. (F) Percentage of apoptotic
(TUNEL-positive) cells present in the new epithelial tongue during re-epithelialisation. Data are mean 6 SEM of 16 frogs (8 male and 8 female).
Significance relative to control data at the same time-point denoted by *P,0.05, ***P,0.001.
doi:10.1371/journal.pone.0073596.g003
Figure 4. Xenopus tropicalis mitosis: TRH increases epidermal mitosis. (A–C) Representative images of Weigert’s stained X. tropicalis
epidermis with black arrows indicating mitotic cells. (D) The graph shows the percentage of mitotic figures identified by Weigert’s staining in the X.
tropicalis epidermis. 200 nuclei were analysed per skin section, with 3 sections per animal counted. (E) The graph displays the total number of DAPI+
nuclei in the new epithelial tongues. Data are mean 6 SEM of 4 frogs (2 male and 2 female). Significance relative to control data at the same time-
point denoted by **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0073596.g004
TRH and Wound Healing in Frog and Human
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Figure 5. Increased re-epithelialisation and proliferation in human skin following 17b-estradiol treatment. (A) Representative H&E
stained sections of human skin punch-wounds following 6 days culture with either vehicle control, 100 nM or 1 mM 17b-estradiol (Est). New epithelial
tongue indicated by red lines, scale bar represents 50 mm. (B) Representative images of Ki-67-TUNEL double-stained sections of human skin punch
TRH and Wound Healing in Frog and Human
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follicle organ culture [45]. This culture medium is essentially
identical to that used in the X. tropicalis cultures described above
(with the exception of a 1:1 dilution with water in the frog assay)
allowing for direct comparisons in wound-healing responses. As
with the comparative frog skin cultures, 17b-estradiol was also
investigated as a positive control for the promotion of wound
healing [39].
(Immuno-)histological Analyses and Quantitative
Immunohistomorphometry
Human skin biopsies were embedded in Shandon Cryomatrix
before cutting longitudinal 6 mm cryosections for further analyses.
Routine histology was performed by staining with Mayer’s
Haematoxylin (Merck, Darmstadt, Germany) and 0.1% Eosin E
(Sigma-Aldrich, St Louis, MO, U.S.A.). Proliferating and
apoptotic cells were analysed by quantitative Ki-67/TUNEL
immunohistomorphometry, using ImageJ software as described
[41]. Nuclei were visualized with 4,6-diamino-2-phenylindole
(DAPI). Sections were stained for a-cytokeratin 6 (CK6) using the
primary antibody (Progen, Heidelberg, Germany) diluted at 1:10.
Detection of CK6 was performed with goat-anti-mouse-IgG-
FITC/2Rhodamine (JIR, Westgrove, PA; USA; 1:200). Involu-
crin detection was preformed as previously described [42]. Images
were captured using a Keyence Biozero-8000 Microscope (Key-
ence Corporation, Osaka, Japan). Quantitative immunohistomor-
phometry of carefully defined reference areas in test and control
sections was performed as described [40–44].
Statistical Analysis
For human and frog skin culture, statistical analysis was carried
out using one-way analysis of variance (ANOVA) with Bonferro-
ni’s post-tests. P values of ,0.05 were regarded as significant.
Results
Frog Serum and Estrogen Enhance Re-epithelialisation
and Proliferation of ex vivo Wounded Adult X. tropicalis
Skin
In a series of preparatory experiments we had established that
full-thickness (,150 mm) skin of adult X. tropicalis provides a viable
tissue source for skin organ culture and is superior in this respect to
X. laevis, whose skin is more fragile and requires lower temperature
culture conditions (data not shown). Six mm punch biopsies of
adult frog skin were wounded via a central 2 mm biopsy (‘‘punch-
in-a-punch’’ design; Figure 1) and cultured in a modified serum-
free growth medium previously optimised for human skin and hair
follicle culture. The quick and easily reproducible measurement
parameter of absolute wound closure was used to planimetrically
quantify re-epithelialisation.
Over 7 days frog skin organ culture in minimal media we
observed a small (,10%) reduction in the wound area
(Figure 2A,D). Since serum has long been appreciated as a
wound-healing promoter in other species [46–48], we tested the
effect of normal frog serum supplementation. Healing was
dramatically accelerated following treatment with 5% adult female
frog (X. laevis) serum (mean 40% wound closure after seven days;
Figure 2A,D). In addition treatment with 17b-estradiol, a widely
accepted wound healing promoter [39], significantly enhanced
wound closure compared to controls (Figure 2A,D). Re-epithelial-
isation appeared to progress unevenly along the wound edge of the
inner punch biopsy (Figure 2A). Although one might expect this
process to proceed evenly across the circular wound, it appears
that a focal area is established, from which migration and
proliferation expands rapidly until the advancing sheet covers the
entire wound area.
To investigate potential wound-healing stimulatory components
in isolated frog serum, we assessed the concentrations of both 17b-
estradiol and TRH by ELISA. Results indicate the serum 17b-
estradiol levels were 29.7 nM (8.1 ng/mL). Serum TRH levels
were below the limit of detection.
Keratinocyte proliferation plays an important role in mamma-
lian re-epithelialisation. In unwounded frog skin (day 0) prolifer-
ation, measured by the proportion of PH3 positive (mitotic) cells,
was low and similar to levels seen in unwounded mammalian skin
(around 3%; Figure 2E). Over the seven days following wounding
and skin organ culture a modest increase in proliferation was
observed in minimal media (Figure 2B,E). However, the addition
of either 5% frog serum or 100 nM 17b-estradiol led to a rapid
and substantial increase in proliferative, PH3 positive cells
(Figure 2B,E). Finally, TUNEL assays were performed to establish
the contribution of apoptosis to the observed wound closure. The
number of apoptotic cells in the wound edge and neo-epidermis
was low (,3%) and essentially unaltered in the presence of frog
serum or 17b-estradiol (Figure 2C,F).
TRH Promotes Re-epithelialisation and Proliferation in
Frog Skin ex vivo Wounds
The neuropeptide TRH is prominently and constitutively
expressed in frog skin [20] and acts as a potent stimulator of
human hair growth [22] and mitochondrial energy metabolism of
human epidermis and hair follicles [23,24]. We therefore
examined the effects of exogenous TRH application on wounded
ex vivo cultured frog skin. The concentrations of TRH investigated
were selected to be comparable with those concentrations
previously shown to stimulate hair growth (10 nM) [22] and the
high concentrations found in the skin of certain frog species such
as X. laevis (10 mM) [20,21].
At the gross morphological level, both 10 nM (equivalent to
3.6 ng/ml) and 10 mM (equivalent to 3.6 mg/ml) TRH signifi-
cantly stimulated wound closure (Figure 3A,D). PH3 analysis
revealed a strong stimulatory effect of TRH on keratinocyte
proliferation at all time-points assessed (Figure 3B,E). Increased
proliferation was also indicated by Weigert’s iron hematoxylin
histochemistry, by which an increased number of mitotic
epidermal cells were identified after TRH treatment, compared
to vehicle controls (Figure 4). As with frog serum, TRH treatment
did not significantly change the number of TUNEL+ apoptotic
cells (Figure 3C,F). These findings provide the first evidence that
this tripeptide neurohormone is a potent stimulator of frog skin
epithelial repair.
wounds following 6 days culture with either vehicle control, 100 nM or 1 mM 17b-estradiol. The white-hatched line demarcates new epithelial
tongue. (C) The graph displays length measurements of the new epithelial tongue (as demarcated by the red lines in A) as analysed from H&E stained
human skin sections following treatment with vehicle control, 100 nM and 1 mM 17b-estradiol. (D) Percentage of proliferative (Ki67-positive) cells in
the new epithelial tongue of vehicle control, 100 nM and 1 mM 17b-estradiol-treated human skin wounds. (E) Percentage of apoptotic (TUNEL-
positive) cells in the new epithelial tongue of vehicle control, 100 nM and 1 mM 17b estradiol-treated human skin wounds. Data are mean6 SEM of 4
female donors. Significance relative to control data denoted by *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0073596.g005
TRH and Wound Healing in Frog and Human
PLOS ONE | www.plosone.org 8 September 2013 | Volume 8 | Issue 9 | e73596
TRH and Wound Healing in Frog and Human
PLOS ONE | www.plosone.org 9 September 2013 | Volume 8 | Issue 9 | e73596
There were no differences observed in dermal proliferation
following 5% FS, 10 nM or 10 mM TRH exposure. Figure S1
indicates the percentage of PH3+ cells in the dermis. This result
was confirmed by Weigert’s iron hematoxylin histochemistry,
which demonstrated no differences in the number of visible mitotic
figures in the dermis (Figure S1).
Human Serum and Estrogen Stimulate Human Skin Re-
epithelialisation and Proliferation ex vivo
To facilitate cross-species comparison we have established a
directly comparable human ex vivo wound healing assay. The
epithelial wound healing response comprises a carefully regulated
combination of keratinocyte proliferation and migration. Thus, we
explored the contribution of proliferation versus cell migration to
epithelial tongue formation in our ex vivo human wound model.
Wounded adult human skin displayed prominent epiboly [49]
within 24 h of wounding, with a compact rim of epidermal
keratinocytes forming an ‘‘epithelial tongue’’ that covered the
exposed dermis at the inner wound edge. As an initial
approximation of re-epithelialisation we measured the overall
length of newly formed inner and outer epithelial tongues. As with
the frog skin organ cultures, the known wound-healing promoter
17b-estradiol [39] significantly stimulated epithelial migration, as
documented by epithelial tongue length measurements, at days 3
and 6 post-wounding at low dose (100 nM) and at days 1, 3 and 6
at high dose (1 mM), compared to controls (Figure 5A,C).
Within the ‘‘epithelial tongues’’, 1 day after standardized punch
wounding, there were relatively few Ki67+ (proliferative) cells
present in the control wounds (,3%) (Figure 5B,D). However, by
day 6 approximately 10% of the cells in the newly formed outer
and inner epithelial tongues of control wounds were Ki67+
(Figure 5B,D). This exactly mirrors the in vivo hyperproliferation
response where a proliferative burst within the epithelial wound
edge occurs .24 h post wounding. In our ex vivo model we
observed increased epithelial tongue proliferation following 17b-
estradiol treatment at the higher dose (1 mM) only (Figure 5B,D).
This suggests that the impact of estrogen at the lower dose is
primarily on epithelial migration, in line with published observa-
tions in vivo [39]. Again, there was little difference in TUNEL+
(apoptotic) cells in the epithelial tongues following 17b-estradiol
treatment compared to vehicle control skin (Figure 5B,E).
Human Skin Re-epithelialisation ex vivo Involves
Sequential Up-regulation of Distinct Differentiation
Programmes: Cytokeratin 6 and Involucrin Expression
We analysed the expression of cytokeratin 6 (CK6), which is
found in human inter-follicular epidermis only upon injury and in
states of hyperproliferation [50–53]. Strong CK6 immunoreactiv-
ity was evident one day post-wounding and was maintained at
high levels thereafter. Interestingly, epidermal CK6 induction
preceded the proliferative peak in control wounds (Figure 6A,C)
supporting evidence that CK6 is a sensitive early marker for
regenerating normal human skin epithelium in situ [29].
17b-estradiol had little effect on CK6 expression, with a small
but significant down-regulation only evident in the first day of
healing. Immunoreactivity for involucrin, a marker of keratinocyte
terminal differentiation, also displayed an early peak at day 1 and
was maintained thereafter at high level (Figure 6B,D). Intriguingly,
the involucrin staining pattern also showed a shift in its localisation
in the epithelial tongue, i.e. from its normal expression pattern with
maximal intensity in the epidermal granular layer to a more diffuse
distribution in all suprabasal layers of the epithelial tongue
(Figure 6B). This resembles the ectopic involucrin expression
pattern previously reported in psoriasis [54], epidermal tumours
[55,56], and cultured skin substitutes [57].
TRH Stimulates Human Skin Re-epithelialisation and
Proliferation
We next investigated the impact of the intracutaneously
generated tripeptide neurohormone, TRH [19,20–22], as a
potential wound-healing promoter in human skin. For this, we
tested two doses of TRH (5 and 10 ng/ml; 14 and 28 nM,
respectively). These concentrations were selected as both had
previously been shown to stimulate ex vivo human hair growth [22].
In addition they were consistent with the lower of the two TRH
doses tested on frog skin organ culture (3.6 ng/ml, equivalent to
10 nM). Both TRH concentrations significantly stimulated
epithelial tongue formation in wounded, organ-cultured human
skin at day 3 post-wounding (P,0.01) (as quantified by measure-
ment of epithelial tongue length), with maximal effects exerted by
10 ng/ml TRH treatment (Figure 7A,C). Quantitative Ki-67
immunohistomorphometry revealed an accelerated onset of
keratinocyte proliferation at day 3 in TRH-treated human
epithelial tongues (Figure 7B,D). As in frog skin wounds, TRH
treatment did not significantly change intraepithelial apoptosis
(TUNEL immunohistomorphometry) (Figure 7B,E). Thus, apop-
tosis-driven remodelling does not constitute a major part of the
wound-healing response in these ex vivo skin cultures. These data
provide the first evidence that TRH is an evolutionarily conserved
stimulator of re-epithelialisation in both adult frog and human
skin.
TRH Up-regulates Wound Healing-associated
Differentiation in Regenerating Human Skin Epithelium
In comparison to vehicle controls, TRH treatment significantly
up-regulated protein expression of the wound healing-associated
keratin, CK6 (Figures 8A,C). This correlated with significantly
increased epithelial tongue migration as early as day 3 of organ
culture (Figure 7). By contrast involucrin immunoreactivity was
not significantly altered by TRH compared to vehicle controls
(Figure 8B,D), suggesting that TRH does not greatly impact on
keratinocyte terminal differentiation under assay conditions.
Discussion
Utilising a comparative approach to investigating cutaneous
wound healing, this study demonstrates for the first time that the
side-by-side analysis of organ-cultured adult frog and human skin
can provide an instructive and novel tool to investigate evolution-
arily conserved, clinically relevant modulators of vertebrate wound
Figure 6. Cytokeratin 6 and Involucrin expression in human skin punch wounds following 17b-estradiol treatment. Representative
images indicating cytokeratin 6 (CK6) expression in control, 100 nM and 1 mM 17b-estradiol (Est)-treated human skin punch wound sections, 6 days
post-wounding. The white-hatched line demarcates new epithelial tongue. (B) Representative images indicating involucrin (Inv) expression in control,
100 nM and 1 mM 17b-estradiol-treated human skin punch wound sections, 6 days post-wounding. The white-hatched line demarcates new
epithelial tongue. (C) Quantification of CK6 immunoreactivity in the new epithelial tongues indicated (A). (D) Quantification of involucrin
immunoreactivity in the new epithelial tongues indicated in (B). Data are mean 6 SEM of 4 female donors. Significance relative to control data
denoted by **P,0.01.
doi:10.1371/journal.pone.0073596.g006
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healing. Recent literature on human skin explants for wound
healing studies [29] has highlighted the utility of such techniques,
in particular the advantages offered over simple in vitro techniques
such as keratinocyte scratch assays [30,31]. The comparative
biology approach advocated here facilitates a reliable assessment
of the potential for therapeutic agents to enhance sub-optimal
wound healing, as found in chronic human skin ulcers. As such, it
provides direct translational relevance.
Frog skin organ culture has been practised since the beginning
of the 20th century [34] though mostly in tadpoles and froglets
[35,58]. Our data highlight the benefits of employing an adult frog
skin ex vivo assay, specifically utilising the skin of X. tropicalis, so as to
model and dissect conserved principles that also underlie adult
human skin healing. As demonstrated by the wealth of literature
dedicated to the study of wound healing and regeneration in
amphibians [10–18], it is clear that these vertebrates provide a
valuable model in which to study these processes, and insights
from these lower vertebrate models may well be relevant to human
wound healing. The adult frog skin assay reported here is intended
to complement, rather than replace, well-established and instruc-
tive embryonic frog wound healing methodologies [59–61].
Indeed, we propose that adult frog skin will provide a powerful
system to facilitate the translation of key findings from these
embryonic/tadpole stage experiments into preclinical human skin
research.
Utilising a combination of the historically well-developed
approaches to frog skin organ culture [32,34,62] with more recent
methodologies for studying ex vivo wound repair and the punch-in-
a-punch design [29,36], we demonstrate here that re-epithelial-
isation of wounded frog skin can be stimulated both with normal
adult female frog serum and with the recognised wound-healing
promoter, 17b-estradiol [39]. Employing a previously described
technique for the serum-free organ culture of full-thickness human
skin [37] and the punch-in-a-punch design [29,36], these effects
are mirrored in the epidermal regeneration of adult human skin in
organ culture, which is also promoted by 17b-estradiol and human
serum. In both assay systems, 17b-estradiol and species-specific
serum can therefore be employed as physiologically relevant
positive control agents.
Although the serum used in these investigations was largely
uncharacterised, it is plausible that the wound-healing promoting
effects of serum supplementation are determined, at least in part,
by the presence of 17b-estradiol. Indeed, Hecker et al [63]
measured serum estradiol levels from male X. laevis frogs to be in
the region of 3 ng/ml (corresponding to approximately 12 nM).
We tested the levels of both 17b-estradiol and TRH in the female
frog serum used in this study, demonstrating a 17b-estradiol
concentration almost 3 times greater than was reported [63] in
male animals. As no trace of TRH could be detected in the serum
we used, we suggest that 17b-estradiol is at least partially
responsible for the wound-promoting effects of serum addition.
The stimulation of re-epithelialisation is likely the result of a
combination of keratinocyte migration and increased proliferation.
Indeed, whereas it is well recognised that epiboly [49] is an
important early response to skin wounding in vitro, both frog and
human skin explants also displayed increased proliferation within
the newly formed epithelial tongues as early as 1 day post-
wounding (Figures 2,3,4). Therefore, whilst epithelial migration
will almost certainly play a role in this initial re-epithelialisation, it
appears that keratinocyte proliferation is also stimulated early in
the repair process.
Since adult frog skin, in particular with respect to wound
healing, has only been sparsely investigated, few well-characterized
antibodies are commercially available for frog skin immunohistol-
ogy. We thus purposely employed readily available histological
and morphometric techniques, and demonstrate that these simple
markers suffice to quantitatively answer basic wound healing
questions such as the extent of re-epithelialisation or epithelial
proliferation/apoptosis. Given that the high cutaneous concentra-
tion of TRH in frog skin is well established [20], our finding raises
the possibility that one of the, as yet poorly understood functions of
intracutaneous TRH may be to facilitate epithelial regeneration
after wounding. As our data has shown that wounded frog skin,
cultured in the absence of serum, may also display spontaneous re-
epithelialisation, this raises the question of whether TRH,
produced and retained within the explants might be responsible
for this. Further experimentation aimed at inhibiting TRH
function in this system is required to address this possibility.
TRH, administered at concentrations that we had previously
shown to stimulate human hair growth and mitochondrial energy
metabolism of human epidermis and hair follicles in vitro [22–24],
also promotes the re-epithelialisation of adult wounded human
skin. On the one hand, this demonstrates that the wound healing-
stimulatory properties of TRH have been conserved over a wide
expanse of vertebrate evolution. On the other, it underscores the
similarities and cross-connections between wound healing and hair
growth and also suggests that known hair growth-promoting
agents also deserve to be explored in a wound-healing context
[27,28].
Clinically, TRH is a particularly interesting candidate wound
healing promoter. It is an unusually stable, well-tested tripeptide
that has long been administered systemically in daily endocrino-
logical practice (i.e.,TRH stimulation test for thyroid function) and
as such is a relatively inexpensive treatment [64]. This greatly
facilitates drug repositioning and subsequent testing of TRH in
clinical wound healing trials.
TRH exerts its effects via the TRH receptor, of which 3 Xenopus
subtypes have been reported in X. laevis [65,66], designated trhr1,
trhr2 and trhr3. This contrasts to mammalian species in which only
2 TRH receptor isoforms have been identified. Differential TRH
responses may therefore be accounted for through signalling via
specific trhr isoforms. In examining the tissue distribution of the trhr
isoforms in X. laevis, Bidaud et al [65,66] identified trhr1 in the
dorsal skin. While that study was performed in X. laevis, the high
degree of conservation of gene expression patterns in X. laevis and
X. tropicalis [67] makes it very likely that the same expression
profile for these genes will be evident in X. tropicalis. Indeed, the X.
Figure 7. TRH stimulates re-epithelialisation and enhances proliferation in wounded human skin. (A) Representative H&E stained
sections of human skin punch-wounds following 6 days culture with either vehicle control or 10 ng/mL TRH. New epithelial tongues indicated by the
white-hatched lines. Scale bars represent 50 mm. (B) Representative images of Ki-67-TUNEL double-stained sections of human skin punch wounds
following 6 days culture with either vehicle control or 10 ng/mL TRH. The white-hatched line demarcates new epithelial tongue. (C) The graph
displays length measurements of the new epithelial tongue (as demarcated by the white-hatched lines in A) as analysed from H&E stained human
skin sections following treatment with vehicle control, 5 ng/mL and 10 ng/mL TRH. (D) Percentage of proliferative (Ki67-positive) cells in the new
epithelial tongue of vehicle control, 5 ng/mL and 10 ng/mL TRH-treated human skin wounds. (E) Percentage of apoptotic (TUNEL-positive) cells in
the new epithelial tongue of vehicle control, 5 ng/mL and 10 ng/mL TRH-treated human skin wounds. Data are mean 6 SEM of 4 female donors.
Significance relative to control data at the same time-point denoted by *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0073596.g007
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Figure 8. TRH increases cytokeratin 6 but not involucrin expression in human skin punch wounds. (A) Representative images indicated
cytokeratin 6 (CK6) expression in control, 5 ng/mL and 10 ng/mL TRH-treated human skin punch wound sections, 6 Days post-wounding. The white-
hatched line demarcates new epithelial tongue. (B) Representative images indicating involucrin (Inv) expression in control, 5 ng/mL and 10 ng/mL
TRH-treated human skin punch wound sections, 6 Days post-wounding. The white-hatched line demarcates new epithelial tongue. (C) Quantification
of involucrin immunoreactivity in the new epithelial tongues indicated in (A). (D) Quantification of CK6 immunoreactivity in the new epithelial
tongues indicated in (B). Data are mean6 SEM of 4 female donors. Significance relative to control data at the same time-point denoted by **P,0.01,
***P,0.001.
doi:10.1371/journal.pone.0073596.g008
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tropicalis genome contains orthologs of these three trhr genes,
previously identified in X. laevis [68].
Normal human skin and/or its appendages express both TRH
and TSH as well as their cognate receptors [19,22,42,43,69], and
TRH stimulates TSH expression in human epidermis [43].
Interestingly, TSH up-regulates the transcription of connective
tissue growth factor, a key promoter of wound healing [9,70] in
human skin appendages [42], and stimulates mitochondrial
biogenesis and energy metabolism in normal human epidermis
[71]. Thus, besides the documented direct stimulatory effects of
TRH on human keratinocyte proliferation [22] and mitochondrial
function [23] in situ, the re-epithelialisation-promoting effects of
TRH seen in wounded frog and human skin in vitro may reflect, in
part, the stimulation of intracutaneous TSH production.
The mechanism(s) through which TRH acts in the frog/human
skin remain(s) to be fully elucidated. TRH binding to a TRH
GPCR isoform would trigger a signalling cascade involving
phospholipase C, an increase in downstream inositol 1,4,5-
trisphosphate (InsP3) production and activation of protein kinase
C. Intriguingly, a recent report using Xenopus embryonic wound
healing assays has shown that both InsP3 and its metabolite,
inositol 1,3,4,5-tetrakisphosphate (InsP4), are able to accelerate the
speed of wound healing [72]. Further signalling events triggered by
TRH binding can involve PKC-dependent or independent
activation of mitogen-activated protein kinase (MAPK). However,
it is not clear whether these signalling events occur in human/frog
skin during wounding, in response to TRH. Indeed, TRH-induced
phosphorylation of epidermal growth factor receptor enhances the
MAPK cascade, and as such it is possible that receptor cross-
regulation is involved in modulating integrated signalling path-
ways. Indeed, as TRH receptor mutations have not been reported
to cause skin abnormalities [73], it is certainly plausible that TRH
may exert its wound healing-promoting effects via TRHR-
independent mechanisms [23]. The precise mechanism of TRH-
signalling in both Xenopus and human skin therefore deserves
further investigation.
An additional mechanism may be the TRH-mediated stimula-
tion of CK6 expression, a wound-healing associated keratin
[52,74]. Knocking-out CK6 in mice delays re-epithelialisation,
despite apparently normal keratinocyte proliferation [74], yet
paradoxically, reports also indicate that CK6 itself may reduce
keratinocyte migration [52]. Interestingly, these newly identified
CK6-regulatory effects of TRH seem to differ between human
hair follicle keratinocytes and regenerating wounded human
epidermis. Microarray analysis had suggested that TRH reduces
CK6 transcription in human hair follicle keratinocytes in situ [22].
In vehicle-treated wounded human skin punches we also saw a
decline of CK6 mRNA levels after 11 days of culture (unpublished
observation). Yet, CK6 protein-associated immunoreactivity was
up-regulated by TRH early on. This suggests that CK6 is
differentially regulated by TRH in human outer root sheath
keratinocytes and wounded human epidermis.
One observation from this study is the lack of a clear
concentration dependence in the response to TRH. Although
only 2 concentrations were assessed in both frog and human
systems, no obvious concentration-mediated changes were seen.
This begs the question whether it is a short ‘spike’ in TRH
concentration that is required to elicit downstream effects, rather
than sustained levels. It is recognised that TRHRs may be rapidly
internalized after TRH binding, thus acting as an agonist-induced
desensitization mechanism [75]. As such, higher concentrations of
TRH may lead to an increase in internalization, reducing the
availability of receptors through which TRH can signal.
In conclusion, we have introduced TRH as a novel, evolution-
arily conserved, neuroendocrine promoter of epidermal regener-
ation that deserves further clinical exploration. In addition we
advocate a comparative biology approach to wound healing
research and report two simple, complementary adult frog and
human skin ex vivo-assays that facilitate the identification and
standardized preclinical testing of clinically relevant stimulators of
wound healing.
Supporting Information
Figure S1 TRH has no impact on dermal proliferation
in X. tropicalis skin explants. (A–D) Representative images of
PH3 immunoreactivity in X. tropicalis skin explants after 7 days
culture with the indicated treatments. White dotted line demar-
cates the Stratum spongiosum and the Stratum compactum (see Figure 1).
(E) The graph displays the percentage of PH3+ cells identified by
analysis of 3 high-powered fields per section, with 3 sections per
animal analysed. (F) The graph shows the percentage of mitotic
figures identified by Weigert’s staining in the X. tropicalis dermis.
200 nuclei were analysed per skin section, with 3 sections per
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